The RELAX ( Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Heart Failure with Preserved Ejection Fraction ) study was a multicenter , randomized trial of sildenafil versus placebo in heart failure with preserved ejection fraction ( HFpEF ) with rigorous entry criteria and extensive phenotypic characterization of participants .